Ovarian steroid cell tumour inducing virilisation in a postmenopausal woman

BMJ Case Rep. 2022 Apr 20;15(4):e249907. doi: 10.1136/bcr-2022-249907.

Abstract

Hyperandrogenism with virilisation de novo in postmenopausal women is exceedingly rare, with aetiology oscillating between ovarian tumours, adrenal tumours, ovarian hyperthecosis and, less frequently, Cushing's syndrome. We report a case of a postmenopausal woman in her late 60s, referred from her primary healthcare physician to a gynaecology appointment due to hirsutism and vasomotor symptoms. At physical examination, clitoromegaly was also identified. Blood tests revealed severe hyperandrogenemia, with total testosterone above 200 ng/dL, but transvaginal ultrasound and abdominal CT were unremarkable. Three months later, abdominal CT was repeated, revealing a moderate heterogeneous enhancement with 18 mm on the left ovary, which was confirmed by transvaginal ultrasound. Total laparoscopic hysterectomy with bilateral adnexectomy was performed. Histopathological examination reported an ovarian steroid cell tumour not otherwise specified on the left ovary and bilateral ovarian hyperthecosis. Two months later, the patient had normal total testosterone and the hirsutism complaints were completely absent.

Keywords: Endocrinology; Obstetrics and gynaecology.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Hirsutism / etiology
  • Humans
  • Hyperandrogenism* / etiology
  • Male
  • Ovarian Neoplasms* / complications
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / surgery
  • Polycystic Ovary Syndrome* / complications
  • Postmenopause
  • Sex Cord-Gonadal Stromal Tumors*
  • Testosterone
  • Virilism / complications

Substances

  • Testosterone